Evidence map›Paper›PMID 28391641›Full record

ReviewFEBS letters2017

Promiscuity in post-transcriptional control of gene expression: Drosophila sex-lethal and its regulatory partnerships.

Rebecca Moschall, Monika Gaik, Jan Medenbach

Open access · hybridAbstract readReview
In one paragraph

Review in FEBS letters, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. TheeLife · 2023
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Auto-regulatory feedback by RNA-binding proteins.Journal of molecular cell biology · 2019
    Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. RNA (New York, N.Y.) · 2018
    Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Rebecca MoschallInstitute of Biochemistry I, University of Regensburg, Germany.
Monika GaikMax Planck Research Group at the Malopolska Centre of Biotechnology, Jagiellonian University, Krakow, Poland.
Jan MedenbachInstitute of Biochemistry I, University of Regensburg, Germany.
University of Regensburg · DEJagiellonian University · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Drosophila RNA-binding protein Sex-lethal (Sxl) is a potent post-transcriptional regulator of gene expression that controls female development. It regulates the expression of key factors involved in sex-specific differences in morphology, behavior, and dosage compensation. Functional Sxl protein is only expressed in female flies, where it binds to U-rich RNA motifs present in its target mRNAs to regulate their fate. Sxl is a very versatile regulator that, by shuttling between the nucleus and the cytoplasm, can regulate almost all aspects of post-transcriptional gene expression including RNA processing, nuclear export, and translation. For these functions, Sxl employs multiple interactions to either antagonize RNA-processing factors or to recruit various coregulators, thus allowing it to establish a female-specific gene expression pattern. Here, we summarize the current knowledge about Sxl function and review recent mechanistic and structural studies that further our understanding of how such a seemingly 'simple' RNA-binding protein can exert this plethora of different functions.

Indexed as

Alternative SplicingAnimalsDrosophilaDrosophila ProteinsFemaleGene Expression Regulation, DevelopmentalMaleModels, BiologicalRNA-Binding ProteinsRNA, MessengerDrosophila ProteinsRNA-Binding ProteinsRNA, MessengerSxl protein, Drosophilaalternative splicingpost-transcriptional regulation of gene expressionRNA-binding proteinsex determinationsex-lethaltranslational control

Identifiers

PMID28391641
PMCPMC5488161
OpenAlexW2604837337

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.